135 related articles for article (PubMed ID: 21116728)
1. Clinical characteristics of rectal cancer involving the anal canal.
Ota M; Fujii S; Ichikawa Y; Suwa H; Tatsumi K; Watanabe K; Tanaka K; Akiyama H; Endo I
J Gastrointest Surg; 2011 Mar; 15(3):460-5. PubMed ID: 21116728
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes after surgical dissection of inguinal lymph node metastasis from rectal or anal canal adenocarcinoma.
Tanabe T; Shida D; Komukai S; Nakamura Y; Tsukamoto S; Kanemitsu Y
BMC Cancer; 2019 Jul; 19(1):733. PubMed ID: 31340778
[TBL] [Abstract][Full Text] [Related]
3. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of lateral lymph node metastasis for advanced low rectal cancer.
Wu ZY; Wan J; Li JH; Zhao G; Yao Y; Du JL; Liu QF; Peng L; Wang ZD; Huang ZM; Lin HH
World J Gastroenterol; 2007 Dec; 13(45):6048-52. PubMed ID: 18023098
[TBL] [Abstract][Full Text] [Related]
5. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
[TBL] [Abstract][Full Text] [Related]
6. Necessity of external iliac lymph nodes and inguinal nodes radiation in rectal cancer with anal canal involvement.
Zheng R; Zhang Y; Chen R; Guan B; Lin Y; Wang B; Li X; Chi P; Chen X; Xu B
BMC Cancer; 2022 Jun; 22(1):657. PubMed ID: 35701738
[TBL] [Abstract][Full Text] [Related]
7. Intersphincteric resection for very low rectal adenocarcinoma: univariate and multivariate analyses of risk factors for recurrence.
Akasu T; Takawa M; Yamamoto S; Ishiguro S; Yamaguchi T; Fujita S; Moriya Y; Nakanishi Y
Ann Surg Oncol; 2008 Oct; 15(10):2668-76. PubMed ID: 18618181
[TBL] [Abstract][Full Text] [Related]
8. Comparative study on the value of anal preserving surgery for aged people with low rectal carcinoma in Jiangsu, China.
Yu DS; Huang XE; Zhou JN
Asian Pac J Cancer Prev; 2012; 13(5):2339-40. PubMed ID: 22901218
[TBL] [Abstract][Full Text] [Related]
9. Stage I rectal cancer: identification of high-risk patients.
Blumberg D; Paty PB; Picon AI; Guillem JG; Klimstra DS; Minsky BD; Quan SH; Cohen AM
J Am Coll Surg; 1998 May; 186(5):574-9; discussion 579-80. PubMed ID: 9583699
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of extramural vascular invasion in T4 rectal cancer.
Bhangu A; Fitzgerald JE; Slesser A; Northover JM; Faiz O; Tekkis P
Colorectal Dis; 2013 Nov; 15(11):e665-71. PubMed ID: 24103008
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection.
Kobayashi H; Mochizuki H; Kato T; Mori T; Kameoka S; Shirouzu K; Sugihara K
Dis Colon Rectum; 2009 Apr; 52(4):567-76. PubMed ID: 19404054
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
Akiyoshi T; Toda S; Tominaga T; Oba K; Tomizawa K; Hanaoka Y; Nagasaki T; Konishi T; Matoba S; Fukunaga Y; Ueno M; Kuroyanagi H
BJS Open; 2019 Dec; 3(6):822-829. PubMed ID: 31832589
[TBL] [Abstract][Full Text] [Related]
13. Who can get the beneficial effect from lateral lymph node dissection for Dukes C rectal carcinoma below the peritoneal reflection?
Sato H; Maeda K; Maruta M; Masumori K; Koide Y
Dis Colon Rectum; 2006 Oct; 49(10 Suppl):S3-12. PubMed ID: 17106812
[TBL] [Abstract][Full Text] [Related]
14. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
[TBL] [Abstract][Full Text] [Related]
15. Local excision in early rectal cancer-outcome worse than expected: a population based study.
Saraste D; Gunnarsson U; Janson M
Eur J Surg Oncol; 2013 Jun; 39(6):634-9. PubMed ID: 23414776
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of apical lymph node metastasis in patients with node-positive rectal cancer.
Peng J; Wu H; Li X; Sheng W; Huang D; Guan Z; Wang M; Cai S
Colorectal Dis; 2013 Jan; 15(1):e13-20. PubMed ID: 23057847
[TBL] [Abstract][Full Text] [Related]
17. [Multivariate prognostic analysis of patients with low and middle rectal cancer after curative resection].
Li CS; Wan DS; Pan ZZ; Zhou ZW; Chen G; Wu XJ; Li LR; Lu ZH; Ding PR; Li Y
Ai Zheng; 2006 May; 25(5):587-90. PubMed ID: 16687079
[TBL] [Abstract][Full Text] [Related]
18. Local recurrence following curative low anterior resection for rectal carcinoma.
Safioleas MC; Moulakakis KG; Stamatakos M; Kountouras J; Lygidakis NJ
Hepatogastroenterology; 2005; 52(61):94-6. PubMed ID: 15783003
[TBL] [Abstract][Full Text] [Related]
19. Risk factors of synchronous inguinal lymph nodes metastasis for lower rectal cancer involving the anal canal.
Wang R; Wu P; Shi D; Zheng H; Huang L; Gu W; Xu Y; Cai S; Cai G
PLoS One; 2014; 9(11):e111770. PubMed ID: 25409168
[TBL] [Abstract][Full Text] [Related]
20. Results of treatment of distal rectal carcinoma since the introduction of total mesorectal excision: a single unit experience, 1994-2003.
Chiappa A; Biffi R; Zbar AP; Luca F; Crotti C; Bertani E; Biella F; Zampino G; Orecchia R; Fazio N; Venturino M; Crosta C; Pruneri GC; Grassi C; Andreoni B
Int J Colorectal Dis; 2005 May; 20(3):221-30. PubMed ID: 15602647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
